Table A.3Surgical treatment effectiveness parameters used in the model

ParameterValueSource
Initial surgical treatment
Proportion of women who have surgical treatment following failed pharmaceutical treatment0.75GDG opinion
Proportion of women who undergo hysterectomy as surgical treatment for menorrhagia0.43Reid606
Proportion of women who undergo TCRE as surgical treatment for menorrhagia0.25Reid606
Proportion of women who undergo MEA as surgical treatment for menorrhagia0.16Reid606
Proportion of women who undergo TBEA as surgical treatment for menorrhagia0.16Reid606
Prevalence of fibroids0.30Vercellini (in Farquhar151)
Proportion of women with fibroids who have surgery (hysterectomy or myomectomy)0.85GDG opinion
Complications after hysterectomy0.086Maresh523
Death after hysterectomy (direct cause)0.00038Maresh523
Average waiting time for hysterectomy83 daysHES data
Average waiting time for ablation94 daysHES data
Recurrence following ablation
Recurrence of menorrhagia following ablation (all methods)0.10Garside review of evidence334
Proportion of women with failed first ablation (all methods) having further treatment1.00Assumption in Garside334
Proportion of women having further treatment who have hysterectomy0.60Cooper555
Proportion of women having further treatment who have repeat ablation0.40Garside review of evidence334
Recurrence of menorrhagia following second ablation0.10Garside review of evidence334
Proportion of women with failed second ablation (all methods) having hysterectomy0.90Professional estimate assumed in Garside334

From: Appendix A, Health economics

Cover of Heavy Menstrual Bleeding
Heavy Menstrual Bleeding.
NICE Clinical Guidelines, No. 44.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2007 Jan.
Copyright © 2007, National Collaborating Centre for Women's and Children's Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.